When Unifeye Vision Partners announced its partnership with Brooks Eye Associates this May, the transaction represented far more than another practice acquisition. The Plano, Texas-based ophthalmology practice marked a calculated geographic expansion that exemplifies how Reeve Waud’s investment philosophy transforms regional healthcare platforms into national powerhouses.
The Texas Market Imperative
Texas presents compelling demographics that make it irresistible for healthcare consolidation. The Dallas-Fort Worth metroplex has experienced 11.2% employment growth since 2020, ranking fourth nationally among major metropolitan areas. More importantly for ophthalmology investors, the region’s 65-and-older population grows at 2.8% annually compared to just 0.2% for younger demographics.
Dr. Dain Brooks, who has served the Plano community since 2013, brings immediate market credibility to Unifeye’s Texas entry. His practice performs comprehensive eye care including cataract surgery, advanced refractive procedures, and retinal care from both clinic and ambulatory surgery center locations. Mike Lehman, Principal with Waud Capital Partners, characterized the partnership as “a pivotal moment and milestone for UVP” that provides “additional resources to continue its growth trajectory in existing and new geographies.”
Building Regional Density Through Strategic Acquisitions
Waud Capital Partners’ approach to healthcare consolidation emphasizes geographic clustering rather than scattered national expansion. This strategy creates operational synergies impossible to achieve with isolated practice acquisitions. Unifeye’s progression in Texas demonstrates this methodology—the company previously partnered with Sweeney Eye Associates, also serving the Dallas market, before adding Brooks Eye Associates.
The firm’s founder, Reeve Waud, has long advocated for building market density through successive acquisitions in high-growth regions. This approach enables shared administrative services, coordinated marketing efforts, and enhanced negotiating power with payers. With 64 clinic locations and 19 ambulatory surgery centers, Unifeye now possesses the scale necessary to establish meaningful market presence across multiple states.
Competitive Positioning Through Market Selection
Reeve Waud’s three-decade investment career provides valuable perspective on market timing and selection. Rather than competing head-to-head with established platforms in saturated markets, Waud Capital Partners identifies emerging opportunities where first-mover advantages remain available. Texas represents exactly this type of strategic opportunity—a large, growing market with fragmented ownership patterns.
Brooks Eye Associates’ philanthropic mission, including Dr. Brooks’ humanitarian eye care missions in India, Mexico, and Ecuador, aligns with the values-driven approach that Waud Capital Partners emphasizes in healthcare investments. This cultural alignment often proves more valuable than pure financial engineering in creating sustainable platform growth.
Financial Engineering Through Geographic Focus
Morgan Stanley Private Credit’s growth investment alongside Waud Capital Partners validates the geographic expansion thesis. The transaction provides Unifeye with capital flexibility while preserving Waud Capital Partners’ control and upside participation. This sophisticated financing structure enables continued expansion without diluting the founding investor’s position.
The ophthalmology market presents compelling fundamentals for geographic expansion strategies. Medicare reimbursement rates provide stability, while demographic trends ensure growing demand. Platforms that achieve regional density can optimize resource allocation, share best practices across locations, and build competitive moats that independent practices cannot match.
Reeve Waud’s investment in Unifeye Vision Partners through the Brooks Eye Associates partnership demonstrates how thoughtful geographic expansion creates compounding value in healthcare services. Rather than pursuing growth for its own sake, Waud Capital Partners builds platforms designed for long-term market leadership.